Tag

China Archives | Page 73 of 154 | Smartkarma

Daily Brief China: Yum China Holdings Inc, Bright Scholar Education, Xiamen International Port H, Kunlun Energy, Kuaishou Technology, Leapmotor, China Tourism Group Duty Free Corp Ltd, Canvest Environmental Protection Group and more

By | China, Daily Briefs

In today’s briefing:

  • Yum China Pursues Primary Listing Conversion On The HKEx
  • Bright Scholar: Cheap Homecoming, Yet Limited Downside
  • Xiamen Port (3378 HK)’s Composite Doc Out; Shareholders To Vote On 16 Sept
  • Kunlun Energy (135 HK): An Excellent Show
  • Kuaishou (1024 HK): 2Q22, Many Encouraging Points Behind “Slowdown”, 48% Upside
  • Leapmotor IPO: The Bull Case
  • Xiamen Port’s H Share Class Meeting on 16 September
  • Kuaishou: Profitability to Improve Further with Monetisation of Overseas Business
  • China Tourism Group A/H Trading – Decent Support from Long-Only but Minimal Retail Participation
  • Canvest Env (1381 HK): Streaming Ahead Despite Tough Time

Yum China Pursues Primary Listing Conversion On The HKEx

By David Blennerhassett

  • Last week Yum China Holdings Inc (9987 HK)  announced it has applied for voluntary conversion to a primary listing on the Hong Kong Stock Exchange.
  • Should all necessary approvals from the HKEx be satisfied, Yum will become dual primary listed on the New York Stock Exchange and the HKEx.
  • This regulatory process, facilitated by rules introduced by the HKEx over the past year, enables the de-listing of the ADRs and the smooth transition to a sole HK listing.

Bright Scholar: Cheap Homecoming, Yet Limited Downside

By David Blennerhassett

  • Bright Scholar Education (BEDU US) (BSE), an operator of schools across China, the UK, and the US, received an Offer earlier this year from Huiyan Yang, the chairperson.
  • Yang is offering US$3.32/ADS – adjusted for the recent reverse split – a 44% premium to the undisturbed price. 
  • Yang controls 92.5% of the votes. There is no shareholder vote on this transaction should a firm Offer unfold.

Xiamen Port (3378 HK)’s Composite Doc Out; Shareholders To Vote On 16 Sept

By David Blennerhassett

  • Back on 2 June, SOE terminal operator Xiamen International Port (3378 HK) announced a pre-conditional Offer of $2.25/share from Xiamen Port Holding, a Fujian SASAC-controlled entity.
  • The pre-conditions  – NDRC, MoC, SAFE, and CSRC – were fulfilled on the 16 August.
  • The Composite Doc is now out. The H-class meeting will be held on the 16 September. There is no tendering condition. Payment should be the 6 October.

Kunlun Energy (135 HK): An Excellent Show

By Osbert Tang, CFA

  • With an 18.6% growth in 1H22 profit from continuing operations, Kunlun Energy (135 HK) has not disappointed us. Natural gas sales segment is a bright spot with solid growth.
  • Net cash swelled to Rmb10.2bn at end-Jun, about 2x more than the level at end-FY21. We estimate this roughly equals to 19% of the current share price. 
  • New project momentum looks healthy and the market seems to have underestimated FY22 earnings. Its 8x and 7.5x PERs for FY22 and FY23 are clearly attractive. 

Kuaishou (1024 HK): 2Q22, Many Encouraging Points Behind “Slowdown”, 48% Upside

By Ming Lu

  • In 2Q22, the company’s adverting revenue increased by 11% YoY, while the market size shrank by 8% YoY.
  • The company raised both of its user base and Time Spent per Daily Active User.
  • The company’s operating margin continued to shrink due to the layoff at the beginning of this year.

Leapmotor IPO: The Bull Case

By Arun George

  • Leapmotor (2007699D HK), a Chinese EV manufacturer, will start its listing hearing for a US$1.5 billion HKEx IPO this week, according to press reports.
  • Leapmotor ranked fifth among the global pure-play EV companies and fourth among the pure-play EV companies based in China as measured by sales volume in 2021. 
  • The key elements of the bull case rest on a solid roadmap, executive capabilities, explosive growth, declining loss margin and declining FCF burn.

Xiamen Port’s H Share Class Meeting on 16 September

By Arun George

  • Xiamen International Port H (3378 HK)‘s composite document is out with the H Shareholders’ class meeting scheduled for 16 September. The IFA considers the offer to be fair and reasonable. 
  • The key conditions are approval by at least 75% of independent H Shareholders (<10% of all independent H Shareholders’ rejection). There is no minimum acceptance condition.
  • This is a done deal. At last close and for a 6 October payment, the gross and annualised spread to the offer is 0.9% and 7.6%, respectively. 

Kuaishou: Profitability to Improve Further with Monetisation of Overseas Business

By Shifara Samsudeen, ACMA, CGMA

  • Kuaishou Technology (1024 HK) reported 2Q2022 results today. Revenue grew 13.4% YoY to RMB21.7bn (vs consensus RMB20.7bn) while reported operating losses dropped to RMB3.1bn (vs consensus RMB4.6bn).
  • Though top line growth of online marketing services has been declining, the company managed to report growth while peers have been facing decrease in revenues.
  • Kuaishou’s domestic biz has turned profitable at the OPM line while there has been significant decrease in Op. losses from the overseas segment.

China Tourism Group A/H Trading – Decent Support from Long-Only but Minimal Retail Participation

By Sumeet Singh

  • China Tourism Group Duty Free Corporation Limited (CDF) raised around US$2.4bn in its H-share listing in Hong Kong, after pricing its IPO at HKD158/share.
  • As per Frost & Sullivan, CDF had 92.3% market share by retail revenue in China duty-free merchandise sales in 2020.
  • In this note, we talk about the deal pricing and the trading dynamics.

Canvest Env (1381 HK): Streaming Ahead Despite Tough Time

By Osbert Tang, CFA

  • The 25.6% increase in net profit for Canvest Environmental Protection Group (1381 HK) in 1H22 is a resilient show given cost inflation and pandemic/lockdowns in the period.
  • Good pipeline should support growth for the next two years as projects under construction/planning accounted for 54% of the existing capacity in Aug.
  • Canvest’s expectation that gearing has peaked suggests that it will start deleverage in next year. This is a positive message in an industry traditionally with weak cashflow.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief China: PetroChina, Yankuang Energy Group, Biocytogen Pharmaceuticals (Beijing), Swire Pacific Ltd-Cl B, Tencent, Hundsun Technologies Inc A, Orient Overseas International, BeiGene Ltd, WM Motor Technology Co Ltd, Golden Eagle Retail and more

By | China, Daily Briefs

In today’s briefing:

  • FTSE China A50 Index Rebalance Preview: PetroChina & EVE Energy Are Potential Adds
  • FTSE China 50 Index Rebalance Preview: Yankuang Energy (1171) Could Replace Shenzhou Intl (2313)
  • Biocytogen (百奥赛图) IPO: Short Term and Long Term Challenges
  • Swire Buyback Update – It’s On, and Regulatorily Constrained
  • Shanghai/​​​​​​​​​​Shenzhen Southbound Connect: Weekly Moves (22 August 2022)
  • Shanghai/​​​​​​​​​​Shenzhen Northbound Connect: Weekly Moves (22 August 2022)
  • Orient Overseas Intl (316 HK): Don’t Overlook the Downhill Risks
  • BeiGene (6160.HK/BGNE.US) 22H1- It Is an Indisputable Fact that BeiGene Is Difficult to Make Profits
  • WM Motor Holding IPO – The Positives – Fast Growth Driven by Its SUV and Mainstream Focus
  • Morning Views Asia: Golden Eagle Retail, KWG Living Group

FTSE China A50 Index Rebalance Preview: PetroChina & EVE Energy Are Potential Adds

By Brian Freitas


FTSE China 50 Index Rebalance Preview: Yankuang Energy (1171) Could Replace Shenzhou Intl (2313)

By Brian Freitas


Biocytogen (百奥赛图) IPO: Short Term and Long Term Challenges

By Ke Yan, CFA, FRM

  • Biocytogen is a leading animal model player in China expanding into biotech. The company launched a downsized deal to  raise up to USD 70m via a Hong Kong listing.
  • In our previous note, we looked at the company business lines and compared the company’s operation with leading animal model players.
  • In this note, we provide an update for the book building. We provide our quick thoughts on the valuation and deal dynamics.

Swire Buyback Update – It’s On, and Regulatorily Constrained

By Travis Lundy

  • And on the 6th Day, Swire Pacific (A) (19 HK) commenced its buyback. 
  • It took until the 6th day for Swire to start its buyback, and now that it has started, we may have a little better idea of the parameters. And impact. 
  • So far, they appear to be bending the rules a little, but it is still the way it should be. So there is still a trade here to do.

Shanghai/​​​​​​​​​​Shenzhen Southbound Connect: Weekly Moves (22 August 2022)

By David Blennerhassett


Shanghai/​​​​​​​​​​Shenzhen Northbound Connect: Weekly Moves (22 August 2022)

By David Blennerhassett


Orient Overseas Intl (316 HK): Don’t Overlook the Downhill Risks

By Osbert Tang, CFA

  • 1H22 is a fantastic period for Orient Overseas International (316 HK) with record earnings. However, with retreat in freight rates YTD, it is likely to mark the cycle peak.
  • OOIL has not seen the usual peak season for transpacific market yet.  Also, supply pressure is mounting as record vessel delivery is scheduled for the next two years.
  • The elevated share price has not reflected that profitability will decline in FY23 and FY24. We see significant downside risk as the market becomes more realistic on earnings.

BeiGene (6160.HK/BGNE.US) 22H1- It Is an Indisputable Fact that BeiGene Is Difficult to Make Profits

By Xinyao (Criss) Wang

  • BeiGene’s product sales in 2022H1 more than doubled YoY, which was a positive sign for commercialization. However, net loss further widened, mainly due to significantly high R&D and SG&A expenses.
  • Tislelizumab and zanubrutinib are not enough to support BeiGene’s high valuation. The success or failure of TIGIT project will be the key to determine how far BeiGene will go.
  • So far, it is still an indisputable fact that BeiGene has profitability issues. That’s why it’s hard for us to be optimistic about this company. 

WM Motor Holding IPO – The Positives – Fast Growth Driven by Its SUV and Mainstream Focus

By Sumeet Singh

  • WM Motor Technology Co Ltd (WMT CH) (WMM) is looking to raise about US$1bn in its upcoming Hong Kong IPO.
  • WM Motor is a smart EV player in China. As of the latest practicable date, it had a total of four main EV models. 
  • In this note, we talk about the positive aspects of the deal.

Morning Views Asia: Golden Eagle Retail, KWG Living Group

By Charles Macgregor

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief China: China Shenhua Energy Co H, Haier Smart Home Co Ltd, China Pacific Insurance, Hansoh Pharmaceutical, Wuxi Biologics, ENN Energy, Alibaba Group, Agile Property Holdings and more

By | China, Daily Briefs

In today’s briefing:

  • Hang Seng Index Rebalance – FOUR Names IN, None Out (The March to 80 Continues)
  • Hang Seng Tech Rebalance – No Name Changes But Lots of Flow
  • HSCEI Rebalance – One In, One Out, 3.1% One-Way Flow
  • Hansoh Pharmaceutical (3692 HK): Strengthening Innovative Portfolio Through In-Licensing
  • Wuxi Biologics (2269.HK) 2022H1 – Hard to Achieve V-Share Rebound
  • ENN Energy (2688 HK): Seeing Sign of an Upturn
  • China Internet Weekly (22Aug22): E-Commerce, Logistics, Online Game, Food Delivery
  • Morning Views Asia: CIFI Holdings, Kawasan Industri Jababeka, Sino-Ocean Service, Times China

Hang Seng Index Rebalance – FOUR Names IN, None Out (The March to 80 Continues)

By Travis Lundy


Hang Seng Tech Rebalance – No Name Changes But Lots of Flow

By Travis Lundy

  • The Hang Seng Index Team announced the index review for the Hang Seng Tech Index Friday after the close. There were no additions or deletions.
  • However, there is a 4.9% one-way turnover on reasonably heavy FAF and capping changes. Sensetime sees a huge FAF increase. Tencent, Meituan, and Kuaishou get re-capped higher. Xiaomi lower.
  • There is a fair bit of flow, but the obvious big name – SenseTime Group (20 HK) – has potential overhang. Watch Haier Smart Home Co Ltd (6690 HK)

HSCEI Rebalance – One In, One Out, 3.1% One-Way Flow

By Travis Lundy


Hansoh Pharmaceutical (3692 HK): Strengthening Innovative Portfolio Through In-Licensing

By Tina Banerjee

  • Hansoh Pharmaceutical (3692 HK) is strengthening its innovative drug pipeline. In August the company in-licensed one clinical stage drug candidate for women health, having large addressable market opportunity in China.
  • Earlier in May, entered into an exclusive license agreement with NiKang Therapeutics and obtained an exclusive license to develop and commercialize NKT2152 for the treatment of cancer within China.
  • Hansoh’s self-developed oncology drug is getting closer to the UK approval through its partner EQRx. The company received approval for one generic oncology drug in China.

Wuxi Biologics (2269.HK) 2022H1 – Hard to Achieve V-Share Rebound

By Xinyao (Criss) Wang

  • WuXi Biologics released 2022H1 results. The Company maintained its growth momentum. We highlight some positive sides. However, gross profit margin decreased. Considering the future trend, margin performance is not optimistic.
  • A drop in demand has already occurred. Meanwhile, after the biologic drug boom has passed, the “low-hanging fruit” is gone, there could be more magnified cyclical problems for WuXi Biologics.
  • As an old generation CXO, it’s difficult for WuXi Biologics to achieve V-shaped rebound or hit new highs.2022 is a good time to offload. Investors can take advantage of it.

ENN Energy (2688 HK): Seeing Sign of an Upturn

By Osbert Tang, CFA

  • Core net profit rose a healthy 10.9% at ENN Energy (2688 HK) in 1H22 despite challenges from pandemic lockdowns and surge in input costs.
  • We expect to see sequential improvement in both dollar margin for gas sales and overall gross margin in 2H22. Excellent integrated energy pipeline should add to earnings momentum.
  • Gearing improved 2.2pp in 1H22 and there is more room to deleverage in 2H22. While the stock’s valuation is not particularly cheap, it has probably already hit the trough. 

China Internet Weekly (22Aug22): E-Commerce, Logistics, Online Game, Food Delivery

By Ming Lu

  • Logistics companies’ revenue grew by over 10%, which reflects the recovery of e-commerce.
  • The market size of Chinese online game continued to shrink in July.
  • Alibaba’s Ele.me sets up a mini-program on TikTok to fight Meituan.

Morning Views Asia: CIFI Holdings, Kawasan Industri Jababeka, Sino-Ocean Service, Times China

By Charles Macgregor

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief China: Huitongda, Lenovo, Meituan, China Shenhua Energy Co H, Tencent and more

By | China, Daily Briefs

In today’s briefing:

  • HSCI Index Rebalance: 24 Adds, 14 Deletes & Changes to Stock Connect
  • Hang Seng TECH Index Rebalance: No Changes BUT Big Turnover
  • Last Week in Event SPACE: Tencent/Meituan, Jardine Matheson, Giordano, Nearmap, Fraser Hospitality
  • Index Rebalance & ETF Flow Recap: S&P/ASX, CSI300, SSE50, HSI, HSCEI, HSTECH, HSCI, CTG IPO, KQ150
  • ECM Weekly (21st Aug 2022) – China Tourism, SoCar, Beauty Farm, ANZ, Max, Judo, Steadfast, Cleanaway

HSCI Index Rebalance: 24 Adds, 14 Deletes & Changes to Stock Connect

By Brian Freitas

  • There are 24 adds and 14 deletes for the Hang Seng Composite Index (HSCI) at the September rebalance to take the number of index constituents up to 518.
  • 19 of the 24 HSCI inclusions will be added to Southbound Stock Connect, while 12 of the 14 HSCI deletions will be removed from Southbound Stock Connect.
  • Five of the HSCI constituents could be removed from Southbound Stock Connect only since the average market cap over the last year is less than HK$5bn.

Hang Seng TECH Index Rebalance: No Changes BUT Big Turnover

By Brian Freitas

  • There are no changes to the index names, but FAF and capping changes will lead to a one-way turnover of 4.5% and one-way flow of HK$3,287m.
  • An increase in the FAF from 3% to 40% will result in passive inflows of HK$1.18bn for SenseTime Group (20 HK) – that is over 5 days of ADV.
  • There are large shorts on some of the stocks that will have passive outflows and some of these positions could be covered on implementation day.

Last Week in Event SPACE: Tencent/Meituan, Jardine Matheson, Giordano, Nearmap, Fraser Hospitality

By David Blennerhassett

  • Chinese food delivery giant Meituan (3690 HK) shed 9% after Tencent (700 HK) reportedly planned to divest its $24bn stake. But it may just be a misunderstanding. Maybe.
  • Given Jardine Matheson Holdings (JM SP)‘s strong underlying operating performance, the 40% discount to NAV – one in which there are discounts of discounts – JMH appears attractive here. 
  • Expect a firm Offer for Nearmap Ltd (NEA AU) shortly. Thoma Bravo’s due diligence is already at an advanced stage. And why Nearmap entered into the break fee. 

Index Rebalance & ETF Flow Recap: S&P/ASX, CSI300, SSE50, HSI, HSCEI, HSTECH, HSCI, CTG IPO, KQ150

By Brian Freitas

  • A busy Friday with the end of the S&P/ASX review period and announcement of changes to the Hang Seng family of indices and FTSE AW/AC at the September rebalance.
  • Monday is the review cutoff for the FTSE TWSE Taiwan 50, STI, FTSE China 50 and A50 indices, among others. STAR50 Sep changes announcement expected post market close on Friday.
  • There were some big inflows into Asia focused ETFs during the week, while the outflows from KraneShares CSI China Internet ETF (KWEB US) continued for yet another week.

ECM Weekly (21st Aug 2022) – China Tourism, SoCar, Beauty Farm, ANZ, Max, Judo, Steadfast, Cleanaway

By Sumeet Singh

  • Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.
  • On the IPO front, China Tourism managed to price its IPO above the mid-point.
  • There were a host of placements and blocks this week across the region.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief China: Chow Tai Fook Jewellery, SKYX Platforms, Sino-Ocean Group, SenseTime Group, Agile Property Holdings and more

By | China, Daily Briefs

In today’s briefing:

  • HSI Index Rebalance: Another Small Step Towards 80 Members, But BIG Impact
  • SKYX Platforms Corp: An Electrical Engineering Innovator That Could Prove To Be A Disruptor In Its Domain
  • Weekly Wrap – 19 Aug 2022
  • Weekly Wrap – 19 Aug 2022
  • HSCEI Index Rebalance: SenseTime (20 HK) Added As FAF Increases Dramatically
  • Chinese Property Weekly – 19 August 2022 – Lucror Analytics
  • Chinese Property Weekly – 19 August 2022 – Lucror Analytics

HSI Index Rebalance: Another Small Step Towards 80 Members, But BIG Impact

By Brian Freitas


SKYX Platforms Corp: An Electrical Engineering Innovator That Could Prove To Be A Disruptor In Its Domain

By Ishan Majumdar

  • This research note is our first on SKYX Platforms, formerly known as Sky Technologies.
  • The company is a distinguished player within the field of electrical engineering and caters mainly to the residential market.
  • Most modern-day smart homes today rely on a large number of IoT (Internet of Things) gadgets coming from different companies and target high-income populations.

Weekly Wrap – 19 Aug 2022

By Charles Macgregor

Lucror Analytics Weekly Wraps provide an overview of all Morning Views comments and reports published by our analyst team in the past week, and also showcase a list of the most-read reports.

In this Insight:

  1. China SCE
  2. Azure Power Global Ltd
  3. China Jinmao Holdings
  4. Guangzhou R&F Properties
  5. Sunac China Holdings

and more…


Weekly Wrap – 19 Aug 2022

By Charles Macgregor

Lucror Analytics Weekly Wraps provide an overview of all Morning Views comments and reports published by our analyst team in the past week, and also showcase a list of the most-read reports.

In this Insight:

  1. China SCE
  2. Azure Power Global Ltd
  3. China Jinmao Holdings
  4. Guangzhou R&F Properties
  5. Sunac China Holdings

and more…


HSCEI Index Rebalance: SenseTime (20 HK) Added As FAF Increases Dramatically

By Brian Freitas

  • SenseTime Group (20 HK)‘s Free-Float Adjustment Factor (FAF) increases from 3% to 40% following lock-up expiry and the stock will replace China Pacific Insurance (2601 HK) in the HSCEI INDEX
  • Using prices from the close on 19 August, estimated one-way turnover is 3.82% and will result in a one-way trade of HK$2,751m at the close on 2 September.
  • Increase in the FAF on a couple of stocks saves them from index deletion in September but is probably not enough to save them from index deletion in December.

Chinese Property Weekly – 19 August 2022 – Lucror Analytics

By Charles Macgregor

The Chinese Property Weekly focuses on providing updates in the Chinese real-estate sector, including recent regulatory and company developments, top and bottom performers, rating actions, as well as a list of bond maturities in the next 30 days.


Chinese Property Weekly – 19 August 2022 – Lucror Analytics

By Charles Macgregor

The Chinese Property Weekly focuses on providing updates in the Chinese real-estate sector, including recent regulatory and company developments, top and bottom performers, rating actions, as well as a list of bond maturities in the next 30 days.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief China: Meituan, Tencent, Trina Solar Co Ltd, JD.com Inc., Weimeizi (Guangdong), Road King Infrastructure and more

By | China, Daily Briefs

In today’s briefing:

  • Meituan Bear Pressure Accelerating
  • Tencent (700 HK): Revenue Decreased for First Time, Margin Recovering, Price Overly Impacted
  • SSE50 Index Rebalance Preview: Sector Rotation To Continue
  • JD.com (9618 HK): Pre-2Q22 Earnings, Will Slow Down and Then Recover from Lockdown
  • Pre-IPO Weimeizi (Guangdong) – The Market Position Is Not Solid
  • Morning Views Asia: Bharti Airtel, Country Garden Holdings Co, Fantasia Holdings Group Co, Meituan

Meituan Bear Pressure Accelerating

By Thomas Schroeder

  • June 27 call to sell strength in line and showing increasing downside pressure below the 185 support (now resistance).
  • Dual top at 210 induced a turn well under trendline resistance. Break of bear wedge support confirmed the macro sell signal.
  • Below 166 targets 140 where a stall in the decline/bounce is due (resistance near 160-66) but expected to give way for a test on the 110 low zone.

Tencent (700 HK): Revenue Decreased for First Time, Margin Recovering, Price Overly Impacted

By Ming Lu

  • In 2Q22, revenue decreased YoY for the first time on record.
  • Unexpectedly, FinTech revenue stopped growing in 2Q22, as users are conservative in borrowing and investing money.
  • However, we still believe Tencent’s stock price is overly impacted.

SSE50 Index Rebalance Preview: Sector Rotation To Continue

By Brian Freitas

  • Over 80% of the way through the review period for the December rebalance, we see 7 stocks in inclusion/exclusion zone. However, there can be a maximum of 5 changes.
  • We estimate a one-way turnover of 3.9% at the December rebalance leading to a one-way trade of CNY 2.85bn.
  • The potential adds have outperformed the potential deletes and the SSE50 Index (SSE50 INDEX) by a wide margin over the last few months.

JD.com (9618 HK): Pre-2Q22 Earnings, Will Slow Down and Then Recover from Lockdown

By Ming Lu

  • Many consumers bought household freezers after the lift of lockdown.
  • Strict rules on physical stores drive consumers to online e-commerce platform.
  • Total express parcels increased by 8% YoY in China in July.

Pre-IPO Weimeizi (Guangdong) – The Market Position Is Not Solid

By Xinyao (Criss) Wang

  • WEIMEIZI develops the oral care market by means of large promotion and marketing so as to attract consumers, which helps Saky become one of the top brands in China.
  • However, with the layout of other long-lasting reputable brands and the entry of new brands, how to maintain the market share in fierce competition has become an important issue.
  • WEIMEIZI’s leading market position is not solid, unless it could create differentiated products and keep up with industry trends closely. 

Morning Views Asia: Bharti Airtel, Country Garden Holdings Co, Fantasia Holdings Group Co, Meituan

By Charles Macgregor

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief China: Meituan, Xinjiang Daqo New Energy, Yashili International Holdings, China Tourism Group Duty Free Corp Ltd, Xiamen International Port H, Shenzhen Dianxiaomi Network Technology, Sinopharm Group Co Ltd H, Country Garden Holdings Co and more

By | China, Daily Briefs

In today’s briefing:

  • Tencent (700 HK) To Divest Meituan (3690 HK) – Impact and Index Implications
  • CSI300 Index Rebalance Preview: Outperformance Continues & Could Keep Going
  • Yashili’s Pre-Condition EGM Approval Secured
  • Tencent’s Potential Sale of Meituan Stake – Read Across to Other Stocks & Index Implications
  • CTG Duty Free H-Share Listing: Not Even Attractive at the Lower End
  • Xiamen Port’s Pre-Condition Satisfied
  • Chinese Ecommerce Firm Checks Out with $110m from SoftBank, Sequoia
  • Sinopharm Group (1099.HK) – Industry Trends Hardly Support High Valuation Expectations
  • Morning Views Asia: Central China Securities, Country Garden Holdings Co, Meituan

Tencent (700 HK) To Divest Meituan (3690 HK) – Impact and Index Implications

By Travis Lundy

  • Reuters this afternoon carried an article that Tencent (700 HK) was seeking to divest “US$24bn” (17%) of $78bn market cap delivery company Meituan (3690 HK) by year-end to mollify domestic regulators.
  • Tencent would seek to launch a share sale within 2022 “if market conditions are favourable.” Meituan shares tanked 9%, immediately.
  • The article suggests disposal via block sale (faster than negotiating with a private buyer), odd given Tencent’s Q1 2022 experience with the JD.com unwind. But it leads to BIG flows.

CSI300 Index Rebalance Preview: Outperformance Continues & Could Keep Going

By Brian Freitas

  • Past the midway mark in the review period, we see 18 potential changes to the Shanghai Shenzhen CSI 300 Index (SHSZ300 INDEX) at the December rebalance.
  • We estimate a one-way turnover of 3.32% at the December rebalance leading to a one-way trade of CNY 8.55bn.
  • The potential adds have outperformed the potential deletes and the Shanghai Shenzhen CSI 300 Index over the last few months, with the outperformance widening over the last few weeks.

Yashili’s Pre-Condition EGM Approval Secured

By Arun George

  • Yashili International Holdings (1230 HK) independent shareholders unanimously approved the proposed transactions at the 16 August EGM, a crucial step for China Mengniu Dairy Co (2319 HK)’s HK$1.20 offer.
  • The remaining pre-condition is the completion of the 25% Yashili acquisition. The completion conditions suggest that this pre-condition is low risk and will likely be completed soon.
  • The value test is only applicable to the scheme. At last close and for a November completion, the gross and annualised spread to the offer is 8.1% and 29.6%, respectively.

Tencent’s Potential Sale of Meituan Stake – Read Across to Other Stocks & Index Implications

By Brian Freitas

  • Tencent (700 HK)‘s reported sale of its Meituan (3690 HK) stake led to a selloff on Meituan and on other companies that Tencent has invested in.
  • There are 10 listed companies where Tencent (700 HK)‘s holding is over US$1bn. Some stakes are more likely to be sold than others. 
  • A complete stake sale will benefit some companies more than others since they are part of a wider array of indices and that will bring in passive flow.

CTG Duty Free H-Share Listing: Not Even Attractive at the Lower End

By Shifara Samsudeen, ACMA, CGMA

  • CTG Duty Free Group has filed for a HKEx listing and plans to raise net proceeds of US$1.98bn at the midpoint of the IPO price range of HK$143.5-165.5 per share.
  • The company’s indicative IPO price range is at a 27-37% discount to the company’s last close of RMB194.75 per share.
  • In this insight, we discuss our key concerns on CTG’s financials and our thoughts on the company’s valuation.

Xiamen Port’s Pre-Condition Satisfied

By Arun George

  • The pre-condition for Xiamen International Port H (3378 HK)’s privatisation offer from Xiamen Port Holding is satisfied. The offer is HK$2.25 per H share. 
  • The key conditions are approval by at least 75% of independent H Shareholders (<10% of all independent H Shareholders’ rejection). There is no minimum acceptance condition.
  • The offer is attractive. At last close and for a 21 October payment, the gross and annualised spread to the offer is 2.7% and 16.0%, respectively.

Chinese Ecommerce Firm Checks Out with $110m from SoftBank, Sequoia

By Tech in Asia

  • Dianxiaomi, a China-based ecommerce software-as-a-service platform, has bagged US$110 million in a series D round.
  • With the latest investment, Dianxiaomi has raised a total of US$210 million this year. In March, the company closed a US$100 million series C round.
  • Founded by Du Jianyin in 2014, the firm specializes in developing infrastructure for cross-border ecommerce

Sinopharm Group (1099.HK) – Industry Trends Hardly Support High Valuation Expectations

By Xinyao (Criss) Wang

  • Over the past few years, Sinopharm’s revenue scale has continued to grow, but its gross profit margin declined due to negative policy pressure. Actually, it isn’t a highly profitable business.
  • As industry leader, Sinopharm will benefit from the increasing industry concentration and further expand market share. The challenge is Sinopharm will face a situation of increasing revenues without increasing profits.
  • For 2022 forecast, revenue YoY growth could be about 5%-7%. Net profit YoY growth could be below 10%., High valuation expectations cannot be supported considering the future industry trend.

Morning Views Asia: Central China Securities, Country Garden Holdings Co, Meituan

By Charles Macgregor

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief China: Giordano International, Consun Pharmaceutical, Central China Real Estate and more

By | China, Daily Briefs

In today’s briefing:

  • Giordano’s Conditional Offer Open, Price Declared Final, Unlikely to Meet 50%+ Voting Threshold
  • Consun Pharmaceutical (1681HK)- High-Priced Acquisition & Good Performance Show Big Upside Potential
  • Morning Views Asia: Anton Oilfield, Central China Securities, West China Cement

Giordano’s Conditional Offer Open, Price Declared Final, Unlikely to Meet 50%+ Voting Threshold

By Arun George

  • Giordano International (709 HK)’s voluntary conditional from the Cheng Yu Tung family (24.57% of outstanding shares) at HK$1.88 per share is open with a first closing date of 5 September.
  • Crucially, the offeror will not increase the offer price. In combination with an ongoing retail recovery, the low-ball offer has little chance of meeting the 50%+ minimum acceptance threshold.
  • While the IFA says the offer is fair and reasonable, key directors will not accept the offer. A deal break implies, at most, another 10% downside to the last close.

Consun Pharmaceutical (1681HK)- High-Priced Acquisition & Good Performance Show Big Upside Potential

By Xinyao (Criss) Wang

  • After a downturn in 2019,Consun has turned things around and achieved amazing results in 2021. Its core business was not affected by VBP. Consun will continue to make further progress.
  • Consun is undervalued if compared with industry average, the peers and considering its large cash balance. Share prices have decent upside potential, driven by fundamentals, promising outlook and favorable policies.
  • Wanbangde’s intention to acquire Consun’s shares at high price would also be a catalyst. We recommended investors to follow Consun closely, which has certain investment value based on our analysis.

Morning Views Asia: Anton Oilfield, Central China Securities, West China Cement

By Charles Macgregor

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief China: China Tourism Group Duty Free Corp Ltd, Giordano International, Lifestyle International Holdings, Alibaba Group, Huadong Medicine Co Ltd A and more

By | China, Daily Briefs

In today’s briefing:

  • China Tourism Group Duty Free (1880 HK) IPO: Offer Details, Index Inclusion, AH Premium
  • Giordano (709 HK): Offer Doc Out. Terms Declared Final
  • Merger Arb Mondays (15 Aug) – Lifestyle Intl, EVOC, Giordano, Yashili, Alliance Aviation, ResApp
  • CTG Duty Free (601888 CH) H-Share IPO: 2Q22/Outlook Updates and Valuation Views
  • China Internet Weekly (15Aug2022): Alibaba, Tencent, Meituan, TikTok, JD, NetEase, Dingdong
  • Huadong Medicine (000963.CH) 2022H1 – Huadong Is Back on Track. If Shares Pullback, Then Be Long

China Tourism Group Duty Free (1880 HK) IPO: Offer Details, Index Inclusion, AH Premium

By Brian Freitas

  • CTG Duty Free (1880 HK) is looking to sell up to 118.176m shares to raise up to US$2.5bn. Pricing at HK$143.5-165.5/share is a 38.6%-29.2% discount to CTG Duty Free (601888).
  • Between 32-37% of the total offer size is being taken by 9 cornerstone investors and they are locked in for 6 months from listing date (expected 25 August).
  • CTG Duty Free (1880 HK) could be added to MSCI China in November, FTSE All-World and FTSE China 50 in March. Southbound Stock Connect could come online on 19 September.

Giordano (709 HK): Offer Doc Out. Terms Declared Final

By David Blennerhassett

  • On the 23 June, the Cheng family made an underwhelming voluntary conditional Offer of $1.88/share for Giordano International (709 HK)
  • The Offer is conditional on the family getting to more than 50% via tendering, and the Cheng’s (and concert parties) control 24.57%.  
  • The Composite Document is now out with a first close on the 5 September.  The Offer Price has now been declared final. That’s a surprise.


CTG Duty Free (601888 CH) H-Share IPO: 2Q22/Outlook Updates and Valuation Views

By Osbert Tang, CFA

  • At the indicated price range, or 24.8-28.6x PER for FY22F and 16.7-19.2x for FY23F, the H-share IPO of China Tourism Group Duty Free Corp (601888 CH) is not attractive enough. 
  • 2Q22 net profit is worse than it appears. Recent Sanya lockdown has wiped off half of the summer peak season which may even negatively affect demand during Golden Week.
  • Consensus forecasts are too optimistic and there may be another 15% downside. Given current macroenvironment, market volatility and earnings uncertainty, risk outweighs return even at the low-end of price range.

China Internet Weekly (15Aug2022): Alibaba, Tencent, Meituan, TikTok, JD, NetEase, Dingdong

By Ming Lu

  • Express parcels increased by 8% YoY in China in July.
  • TikTok was still the top non-game app in the world in July.
  • Meituan raised its prices of bike sharing on August 10.

Huadong Medicine (000963.CH) 2022H1 – Huadong Is Back on Track. If Shares Pullback, Then Be Long

By Xinyao (Criss) Wang

  • Huadong released encouraging 2022H1 results. After a significant decline due to the loss of VBP bid for core varieties, Huadong is out of trouble and back on track now.
  • The future profit contribution would be on medical cosmetology and industrial microorganisms businesses. For 2022 forecast, revenue YoY growth is below 10%, and net profit YoY growth is above 15%.
  • Due to unfriendly macro environment, Huadong’s share price could face a correction. But based on its promising outlook, we recommend that investors could take advantage of the pullback to long.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief China: China Tourism Group Duty Free Corp Ltd and more

By | China, Daily Briefs

In today’s briefing:

  • ECM Weekly (14th Aug 2022) – China Tourism, A/H Listing, Hongjiu Fruit, Socar, Betagro, ThaiBev, GQG
  • Weekly Deals Digest (14 Aug) – CTG Duty Free, OZ Minerals, Lifestyle Intl., EVOC, MACA, MyDeal

ECM Weekly (14th Aug 2022) – China Tourism, A/H Listing, Hongjiu Fruit, Socar, Betagro, ThaiBev, GQG

By Sumeet Singh

  • Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.
  • On the IPO front, China Tourism launched its US$2.5bn IPO. 
  • There were no major placements this week and it likely to remain that way in the near future owing to it being earnings season.

Weekly Deals Digest (14 Aug) – CTG Duty Free, OZ Minerals, Lifestyle Intl., EVOC, MACA, MyDeal

By Arun George


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars